⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMNN News
Imunon, Inc. Common Stock
IMUNON to Present Phase 3 OVATION 3 Study of IMNN-001 in Advanced Ovarian Cancer at IGCS 2025 Annual Global Meeting
globenewswire.com
IMNN
IMUNON to Present New Translational Data from Phase 2 OVATION 2 Study of IMNN-001 at SITC 40th Annual Meeting
globenewswire.com
IMNN
IMUNON Invited to Present PlaCCine® DNA Technology Proof-of-Concept Data in Platform Presentations at Leading Vaccine Conferences
globenewswire.com
IMNN
IMUNON to Present Phase 3 Ovarian Cancer Study of IMNN-001 at ESMO Congress
globenewswire.com
IMNN